# RECCE® 327

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/recce-327
Canonical HTML page: https://getbiobrief.com/entity/recce-327

## Recent coverage (1 stories)

### Recce Secures Brazilian Patent for Synthetic Anti-Infective Platform
2026-03-24 03:24:15 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Recce Pharmaceuticals has been granted a pivotal patent in Brazil for its proprietary synthetic anti-infectives platform, marking a strategic expansion into South America's largest healthcare market. This intellectual property milestone strengthens the company's global protection for its novel class of broad-spectrum antibiotics designed to combat the escalating threat of antimicrobial resistance.
Full story: https://getbiobrief.com/story/recce-pharmaceuticals-brazil-patent-grant-anti-infectives

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.